Cerebrovasc Dis 2012;33:525–531

Leukoaraiosis Predicts Poor 90-Day Outcome after Acute Large Cerebral Artery Occlusion

Henninger N.a, b · Lin E.b · Baker S.P.c · Wakhloo A.K.d · Takhtani D.d · Moonis M.b
aDepartment of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass., and Departments of bNeurology, cQuantitative Health Sciences and Cell Biology, and dRadiology, University of Massachusetts Medical School, Worcester, Mass., USA
email Corresponding Author


 goto top of outline Key Words

  • Acute stroke
  • CT
  • Leukoaraiosis
  • Outcome
  • Tissue plasminogen activator
  • Thrombolysis

 goto top of outline Abstract

Background: To date limited information regarding outcome-modifying factors in patients with acute intracranial large artery occlusion (ILAO) in the anterior circulation is available. Leukoaraiosis (LA) is a common finding among patients with ischemic stroke and has been associated with poor post-stroke outcomes but its association with ILAO remains poorly characterized. This study sought to clarify the contribution of baseline LA and other common risk factors to 90-day outcome (modified Rankin Scale, mRS) after stroke due to acute anterior circulation ILAO. Methods: We retrospectively analyzed 1,153 consecutive patients with imaging-confirmed ischemic stroke during a 4-year period (2007–2010) at a single academic institution. The final study cohort included 87 patients with acute ILAO subjected to multimodal CT imaging within 24 h of symptom onset. LA severity was assessed using the van Swieten scale on non-contrast CT. Leptomeningeal collaterals were graded using CT angiogram source images. Hemorrhagic transformation (HT) was determined on follow-up CT. Multivariate logistic regression controlling for HT, treatment modality, demographic, as well as baseline clinical and imaging characteristics was used to identify independent predictors of a poor outcome (90-day mRS >2). Results: The median National Institutes of Health Stroke Scale (NIHSS) at baseline was 15 (interquartile range 9–21). Twenty-four percent of the studied patients had severe LA. They were more likely to have hypertension (p = 0.028), coronary artery disease (p = 0.015), poor collaterals (p < 0.001), higher baseline NIHSS (p = 0.003), higher mRS at 90 days (p < 0.001), and were older (p = 0.002). Patients with severe LA had a uniformly poor outcome (p < 0.001) irrespective of treatment modality. Poor outcome was independently associated with higher baseline NIHSS (p < 0.001), worse LA (graded and dichotomized, p < 0.001), reduced leptomeningeal collaterals (graded and dichotomized, p < 0.001), presence of HT (p < 0.001), presence of parenchymal hemorrhages (p = 0.01), baseline mRS (p = 0.002), and older age (p = 0.043). The association between severe LA (p = 0.0056; OR 13.86; 95% CI 1.94–∞) and baseline NIHSS (p = 0.0001; OR 5.11; 95% CI 2.07–14.49 for each 10-point increase) with poor outcome maintained after adjustment for confounders in the final regression model. In this model, there was no significant association between presence of HT and poor outcome (p = 0.0572). Conclusion: Coexisting LA may predict poor functional outcome in patients with acute anterior circulation ILAO independent of other known important outcome predictors such as comorbid state, admission functional deficit, collateral status, hemorrhagic conversion, and treatment modality.

Copyright © 2012 S. Karger AG, Basel

goto top of outline Introduction

Intracranial large artery occlusion (ILAO) in the anterior circulation accounts for a significant number of ischemic strokes and predicts a poor outcome [1,2,3]. However, factors modifying the outcome following acute ILAO remain incompletely characterized. Knowledge of such aspects appears paramount to aid in the clinical decision making and to help identifying those patients at high risk or unlikely benefit from advanced treatment strategies, such as thrombolysis or endovascular approaches to therapy. Originally noted as diffuse, non-specific subcortical white matter lesions on CT, leukoaraiosis (LA) is a common finding among patients with ischemic stroke and has been associated with poor post-stroke outcomes as well as increased risk for recombinant tissue plasminogen activator (rtPA)-associated intracranial hemorrhage [4,5,6,7]. LA has been associated with reduced brain perfusion and cerebrovascular reactivity and may therefore considerably decrease penumbral survival and negatively affect outcome [8,9]. Yet, contribution of LA to outcome in stroke patients with ILAO remains to be clarified. To further elucidate this issue, we sought to determine the association between LA severity as assessed by non-contrast CT (NCCT) and 90-day outcomes in patients following acute anterior circulation ILAO.


goto top of outline Methods

goto top of outline Patient Selection and Clinical Data

This study was Institutional Review Board approved and Health Insurance Portability and Accountability Act compliant. We analyzed data from 1,153 consecutive adult patients with imaging-confirmed diagnosis of ischemic stroke evaluated at a single academic institution between January 2007 and October 2010 (fig. 1). Patients were included if they had admission NCCT, followed by CT angiogram (CTA) and perfusion CT (CTP) performed within 24 h after time of symptom onset. Time of onset was defined as either witnessed symptom onset or time of last known well for unwitnessed events. Patients were excluded if there was no evidence of intracranial arterial occlusion on CTA in the anterior circulation [internal carotid artery (ICA) to the M2 segment of the middle cerebral artery (MCA)]. Three patients with angiographically proven proximal M3 occlusion were included as CT imaging was consistent with M2 occlusion suggesting clot migration during neurointervention. Further, only patients with documented perfusion deficit on their CTP images were included to avoid confounding by stroke mimics in the setting chronic ILAO. Time-to-CTP was defined as the time (min) between symptom onset and completion of the CTP imaging protocol. National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) score were assessed at the time of initial presentation as part of the admission workup. Patients were allocated to endovascular therapy according to our institutional protocol. Patient demographics, admission vital signs, laboratory data, comorbidities, preadmission medications, stroke risk factors, and stroke etiology [using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification] [10] were collected on all patients by review of the medical chart. Follow-up mRS was obtained at 90 days during follow-up in our stroke prevention clinic by a stroke-trained physician, certified in mRS [11]. When the mRS was unavailable, the same observers reconstructed the score from the case description, according to the mRS criteria [12].

Fig. 1. Flow chart for the study. Patient exclusion as well as distribution according to outcome. * Note that this number includes patients transferred from referring hospitals to our facility, which serves as the regional tertiary care referral center.

goto top of outline Neuroimaging Protocol

All CT sequences were performed on a 64-row detector Philips scanner. NCCT was performed in a non-helical mode at 120 KvP and 200 mA with data reconstruction at 5 mm axial slices. CTA was performed using 64 × 0.625 mm detector configuration with a pitch of 0.673 from the arch of aorta to the vertex using 120 KvP, 300 mA, and 0.5 s rotation time. Patients received 60–80 ml of Isovue 370 (Bracco Diagnostics, Princeton, N.J., USA) at a rate of 4 mm/s through a power injector followed by 40 ml saline. 3D orthogonal maximum intensity projection images were created in 3 planes. CTP was performed with detector configuration of 64 × 0.625 mm at 80 KvP and 100 mAs creating 4 slices of 10 mm thickness (total coverage 40 mm). The plane of imaging was parallel to the floor of the anterior cranial fossa starting just above the orbits. Thirty cycles were obtained at 2 s (total duration of 60 s). CTP data were analyzed utilizing a stand-alone version of CTP software developed by Philips Medical Systems (Cleveland, Ohio, USA), which automatically calculated mean transit time and cerebral blood volume defects as previously described in detail [13]. The anterior cerebral artery was used for arterial input function [14].

goto top of outline Image Review and Analysis

Admission NCCT, CTA, and CTP were reviewed independently and blindly to both clinical data and follow-up scans by two experienced readers. Disagreements were resolved by consensus. Variable window width and center level settings were used for optimal ischemic hypoattenuation detection with NCCT and CTA images [15,16]. Presence and extent of LA was assessed utilizing the van Swieten Scale (VSS) grading the white matter lesions for the regions anterior and posterior to the central sulcus on a 3-point scale from 0 (no LA) to 2 (confluent white matter involvement from the ventricles to the grey matter). Summing the score from the anterior and posterior region provided a total score ranging from 0–4 [17]. In the present study, LA was separately assessed in both hemispheres. After un-blinding, only the score from the non-ischemic hemisphere was considered. Location of occlusions within arterial segments was noted on CTA. CTA source images were used to assess for the presence of collateral vessels as previously described [15]. Briefly, leptomeningeal collaterals were graded on a 5-point scale (from 1 denoting absence to 5 denoting exuberant collaterals) compared to the contralesional unaffected side. Hemorrhagic transformation (HT) on follow-up imaging was determined according to the ECASS (European Cooperative Acute Stroke Study) definition [18]. To avoid confounding we also dichotomized the degree of LA [VSS 0–2 (absent to moderate) vs. 3–4 (severe)], collateral status [1–2 (poor) vs. 3–5 (good)], HT (absent vs. present), site of intracranial occlusion proximal (ICA–M1) versus distal (M2–M3), and treatment modality [no therapy vs. intravenous (i.v.) rtPA and/or endovascular treatment]. Lastly, since i.v. rtPA represents the approved therapy for patients without contraindications, treatment modality was also included as a trichotomized variable (no therapy vs. i.v. rtPA vs. endovascular treatment).

goto top of outline Statistics

Continuous variables are reported as mean ± SD or as median ± interquartile range (IQR). Categorical variables are reported as proportions. Univariate analysis was used to test the association between baseline characteristics and dichotomized variables with the 90-day mRS using the χ2 test, Fisher’s exact test, Student’s t test, and Mann-Whitney U test as appropriate for dichotomous or continuous variables (table 1). Multivariate logistic regression with forward elimination (probability value for elimination of 0.1) was used to identify independent predictors for good outcome (90-day mRS ≤2). Variables significantly associated with a good outcome in the univariate analysis (p < 0.1) were included in the multivariate logistic model (PASW Statistics 18, Chicago, Ill., USA). Given their reported association with clinical outcomes, we repeated this analysis forcing the following additional variables into the model: time-to-CTP, acute intervention, pre-stroke mRS, site of intracranial occlusion, and atrial fibrillation. The final model was fitted using exact logistic regression (Log Xact, Cytel Inc., Version 8.0, Cambridge, Mass., USA).

Table 1. Baseline characteristics (unadjusted) of the studied patient population as stratified by LA severity


goto top of outline Results

Of the 1,153 patients included in the database, 115 subjects were identified as having acute isolated anterior circulation ILAO involving a single hemisphere. Nineteen subjects were excluded due to poor image quality. Nine patients had no perfusion deficit (all had a low NIHSS of ≤4 and incomplete vascular occlusion). Baseline characteristics are summarized in table 1.

Univariate analysis showed that poor 3-month outcome (mRS > 2) was associated with higher baseline NIHSS (p < 0.001), worse LA (graded and dichotomized, p < 0.001; fig. 2a), reduced leptomeningeal collaterals (graded and dichotomized, p < 0.001), presence of HT (p < 0.001), presence of parenchymal hemorrhages [18] (PH1 and PH2, p = 0.01), baseline mRS (p = 0.002), and older age (p = 0.043). There was a significant association between LA and collateral status (p < 0.001).

Fig. 2.a Functional outcome at 90 days (mRS) stratified by severity of LA grades (VSS 0–2 vs. 3–4, p < 0.001). b Relative frequency of parenchymal type hemorrhages (PH1 and PH2) and poor outcome (mRS 3–6) stratified according to LA severity.

After adjustment (table 2), it appeared that poor outcome was associated with severe LA (OR 13.86, 95% CI 1.94–∞, p = 0.0056) and baseline NIHSS (for each 10-point increase OR 5.11, 95% CI 2.07–14.49, p = 0.0001). There was a trend for an association between presence of HT and poor outcome (p = 0.0572). These results did not change after forcing additional variables into the statistical model.

Table 2. Factors independently associated with poor outcome at 90 days

There was no significant association between LA grade and good recanalization (TIMI ≥2, p = 0.388). Good recanalization was achieved in 74% of patients subjected to endovascular therapy with no significant difference in the recanalization rates between patients with good versus poor outcome (p = 0.194) in this subgroup.

Finally, there was no significant association between LA grade and parenchymal hemorrhages (p = 0.077) and there appeared to be a dissociation between outcome and the relative frequency of parenchymal hemorrhages as indicated by the similar incidence in patients with a VSS of 4 (who had a uniformly poor outcome) and a VSS of 0 or 1 (fig. 2b).


goto top of outline Discussion

In our study, approximately one fourth of patients with acute anterior circulation ILAO had severe LA on baseline CT. After accounting for relevant confounders, presence of severe LA was independently associated with the risk for a poor outcome after ILAO. In fact, ∼70% of patients in this subgroup were either severely disabled or dead at 90 days. These findings add to the notion that LA is an important risk factor for poor outcome after ischemic stroke [5,7,19,20,21,22,23]. Interestingly, other common contributors to a poor outcome, such as the site of arterial occlusion, presence of HT, or treatment modality [1,2,3,24,25,26], did not appear to modify the outcome in the studied patient group.

Common risk factors associated with LA include aging, arterial hypertension, diabetes mellitus, and cardiac disease [27,28]. Indeed, we have found that patients with severe LA were more likely to have hypertension and coronary artery disease, and they were older. Age, which is an important non-modifiable risk factor for ischemic stroke and poor post-stroke outcome [29], was associated with outcome in our study. However, this association was no longer present following multivariate analysis. Similar observations have been reported and may suggest that the degree of LA, rather than biological age alone, is an important modifier of outcome in the elderly [5]. This notion is further substantiated by a recent report demonstrating that moderate to severe LA is associated with increased risk for poor outcome in young ischemic stroke patients [22].

The mechanisms underlying the influence of LA on functional outcome are not entirely clear. LA has been associated with spontaneous and thrombolysis-related intracranial hemorrhage as well as hematoma expansion [30,31,32]. While there was an increasing incidence of parenchymal hemorrhages with worsening LA in our study, this observation did not reach statistical significance. Further, among patients with the most severe LA grade (VSS 4), only 1 patient developed a parenchymal hemorrhage (PH1) indicating that mechanisms different from HT determined outcome in these patients [6]. Impaired brain recovery mechanisms and a reduced brain reserve capacity for injury have been suggested [33]. In addition, reduced penumbral survival following acute ischemic stroke, possibly due to chronically impaired tissue perfusion and cerebrovascular reactivity, has been described in patients with severe LA [8,9,34]. Our study provides new insight by showing a significant inverse correlation between LA severity and robustness of leptomeningeal collaterals, indicating a collective role in the reduction of autoregulatory mechanisms with subsequently aggravated tissue damage.

Major strengths of this study are the large sample size of a hospitalized, homogenous patient population undergoing multimodal CT imaging and the collection of extensive clinical information. Our study and this analysis are unique and add novel information compared with prior reports [5,23,35]. The approach is contemporary and important as it uses CT technology that is now frequently applied in most centers worldwide as the first-line imaging method in acute stroke prior to patient selection for different acute therapies due to its ease of access, rapidness, and reliability. We investigated various variables that have been associated with a poor outcome in the setting of large arterial stroke as well as LA. We included patients that received various treatment modalities allowing utilization of data on LA as a potential additional clinical marker for the assessment of risk and prognosis in acute ILAO.

Our study has several limitations. First, our study was retrospective in nature and the number of observations per subgroup was limited. The findings of this study require testing in a prospective study with a much larger sample size. Second, while our data shows a strong association between LA and outcome, a causal relationship remains to be established. Third, misclassification of LA is possible given the CT-based visual grading system. However, in contrast to MRI, CT scans are broadly available, routinely used in the early evaluation of stroke patients, and our approach has been found to be a reliable method in prior studies without requiring time consuming post-processing [5,17,20,30]. Lastly, our results are exclusive to a highly selected patient population. However, these patients are unique in that they often respond poorly to systemic thrombolysis and are therefore frequently considered for aggressive treatment strategies involving endovascular techniques [24,25]. Identifying markers associated with a poor outcome in this population is an important goal that may ultimately help improve future patient selection for therapy to maximize their risk-to-benefit ratio.

In conclusion, we describe a significant association of LA with poor functional outcome in a large cohort of patients with anterior circulation ILAO independent of other known important outcome predictors such as comorbid state, admission functional deficit, collateral status, hemorrhagic conversion, and treatment modality.


goto top of outline Acknowledgements

This study was supported by institutional funds.


goto top of outline Disclosure Statement

N.H., E.L., S.P.B., D.T., A.K.W. and M.M. report no conflicts of interest.

 goto top of outline References
  1. Smith WS, Lev MH, English JD, Camargo EC, Chou M, Johnston SC, Gonzalez G, Schaefer PW, Dillon WP, Koroshetz WJ, Furie KL: Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 2009;40:3834–3840.

    External Resources

  2. Gasparotti R, Grassi M, Mardighian D, Frigerio M, Pavia M, Liserre R, Magoni M, Mascaro L, Padovani A, Pezzini A: Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome. AJNR Am J Neuroradiol 2009;30:722–727.
  3. Poisson SN, Nguyen-Huynh MN, Johnston SC, Furie KL, Lev MH, Smith WS: Intracranial large vessel occlusion as a predictor of decline in functional status after transient ischemic attack. Stroke 2011;42:44–47.

    External Resources

  4. Pantoni L: Leukoaraiosis: from an ancient term to an actual marker of poor prognosis. Stroke 2008;39:1401–1403.
  5. Arsava EM, Rahman R, Rosand J, Lu J, Smith EE, Rost NS, Singhal AB, Lev MH, Furie KL, Koroshetz WJ, Sorensen AG, Ay H: Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 2009;72:1403–1410.
  6. Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR: Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS RT-PA stroke study. Cerebrovasc Dis 2008;26:120–125.
  7. McMurtray AM, Liao A, Haider J, Licht E, Mendez MF: Cognitive performance after lacunar stroke correlates with leukoaraiosis severity. Cerebrovasc Dis 2007;24:271–276.
  8. Brown WR, Thore CR: Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011;37:56–74.
  9. Uh J, Yezhuvath U, Cheng Y, Lu H: In vivo vascular hallmarks of diffuse leukoaraiosis. J Magn Reson Imaging 2010;32:184–190.

    External Resources

  10. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
  11. Quinn TJ, Lees KR, Hardemark HG, Dawson J, Walters MR: Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke 2007;38:2257–2261.
  12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
  13. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, Pineda C, Serena J, van der Schaaf I, Waaijer A, Anderson J, Nesbit G, Gabriely I, Medina V, Quiles A, Pohlman S, Quist M, Schnyder P, Bogousslavsky J, Dillon WP, Pedraza S: Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979–985.
  14. Wintermark M, Lau BC, Chien J, Arora S: The anterior cerebral artery is an appropriate arterial input function for perfusion-CT processing in patients with acute stroke. Neuroradiology 2008;50:227–236.

    External Resources

  15. Lima FO, Furie KL, Silva GS, Lev MH, Camargo EC, Singhal AB, Harris GJ, Halpern EF, Koroshetz WJ, Smith WS, Yoo AJ, Nogueira RG: The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion. Stroke 2010;41:2316–2322.
  16. Lev MH, Farkas J, Gemmete JJ, Hossain ST, Hunter GJ, Koroshetz WJ, Gonzalez RG: Acute stroke: improved nonenhanced CT detection – benefits of soft-copy interpretation by using variable window width and center level settings. Radiology 1999;213:150–155.
  17. van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J: Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080–1083.
  18. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA 1995;274:1017–1025.
  19. Putaala J, Kurkinen M, Tarvos V, Salonen O, Kaste M, Tatlisumak T: Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology 2009;72:1823–1829.
  20. Koton S, Schwammenthal Y, Merzeliak O, Philips T, Tsabari R, Orion D, Dichtiar R, Tanne D: Cerebral leukoaraiosis in patients with stroke or TIA: clinical correlates and 1-year outcome. Eur J Neurol 2009;16:218–225.
  21. Streifler JY, Eliasziw M, Benavente OR, Alamowitch S, Fox AJ, Hachinski VC, Barnett HJ: Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis. Stroke 2002;33:1651–1655.
  22. Putaala J, Haapaniemi E, Kurkinen M, Salonen O, Kaste M, Tatlisumak T: Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients. Neurology 2011;76:1742–1749.
  23. Fu JH, Chen YK, Chen XY, Mok V, Wong KS: Coexisting small vessel disease predicts poor long-term outcome in stroke patients with intracranial large artery atherosclerosis. Cerebrovasc Dis 2010;30:433–439.
  24. Nguyen TN, Babikian VL, Romero R, Pikula A, Kase CS, Jovin TG, Norbash AM: Intra-arterial treatment methods in acute stroke therapy. Front Neurol 2011;2:9.
  25. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, Akhtar N, Orouk FO, Salam A, Shuaib A, Alexandrov AV: Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–954.
  26. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, Palmerini F, Biagini S, Comi G, Previdi P, Silvestrelli G: Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008;39:2249–2256.
  27. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–659.
  28. Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O’Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D: Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (leukoaraiosis and disability in the elderly) study. Cerebrovasc Dis 2006;21:315–322.
  29. Auriel E, Gur AY, Uralev O, Brill S, Shopin L, Karni A, Shenhar Tsarfaty S, Bornstein NM: Characteristics of first ever ischemic stroke in the very elderly: profile of vascular risk factors and clinical outcome. Clin Neurol Neurosurg 2011;113:654–657.
  30. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM: Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007;68:1020–1024.
  31. Won YS, Chung PW, Kim YB, Moon HS, Suh BC, Lee YT, Park KY: Leukoaraiosis predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage. Eur Neurol 2010;64:253–257.

    External Resources

  32. Lou M, Al-Hazzani A, Goddeau RP Jr, Novak V, Selim M: Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke 2010;41:34–40.
  33. Smith EE: Leukoaraiosis and stroke. Stroke 2010;41:S139–S143.

    External Resources

  34. Ay H, Arsava EM, Rosand J, Furie KL, Singhal AB, Schaefer PW, Wu O, Gonzalez RG, Koroshetz WJ, Sorensen AG: Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 2008;39:1409–1413.
  35. Aries MJ, Uyttenboogaart M, Vroomen PC, De Keyser J, Luijckx GJ: TPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 2010;17:866–870.

 goto top of outline Author Contacts

Nils Henninger, MD
Department of Neurology, Beth Israel Deaconess Medical Center
Harvard Medical School, 330 Brookline Ave, Palmer 127
Boston, MA 02215 (USA)
Tel. +1 617 632 8911, E-Mail nhenning@bidmc.harvard.edu

 goto top of outline Article Information

Received: November 12, 2011
Accepted: February 15, 2012
Published online: April 25, 2012
Number of Print Pages : 7
Number of Figures : 2, Number of Tables : 2, Number of References : 35

 goto top of outline Publication Details

Cerebrovascular Diseases

Vol. 33, No. 6, Year 2012 (Cover Date: June 2012)

Journal Editor: Hennerici M.G. (Mannheim)
ISSN: 1015-9770 (Print), eISSN: 1421-9786 (Online)

For additional information: http://www.karger.com/CED

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.